口腔疼痛和阿尔茨海默病:前性队列和横截面分析
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, P.R. China.
Journal of dental research
|February 11, 2026
概括
口腔疼痛 (OP) 与阿尔茨海默病 (AD) 风险增加30.7%有关. 保持口腔健康可以降低AD风险和认知能力下降,可能通过神经免疫路径.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 有限的阿尔茨海默病 (AD) 治疗有效性需要关注可修改的风险因素.
- 口腔疼痛 (OP) 是一种炎症性疾病,是神经退行症的潜在贡献者.
- 了解口腔健康和认知衰退之间的联系对于预防策略至关重要.
研究的目的:
- 调查口腔疼痛 (OP) 与患阿尔茨海默病 (AD) 的风险之间的关联.
- 检查OP,认知表现和大脑结构之间的关系.
- 探索可能的神经免疫通路,将OP与AD联系起来.
主要方法:
- 分析了来自490,035名没有基线AD的参与者的英国生物库数据.
- 分类为口腔疼痛 (OP) 和口腔无疼痛组.
- 考克斯对AD风险的比例危险模型和对认知和大脑结果的通用线性模型.
主要成果:
- 口腔疼痛 (OP) 与阿尔茨海默病 (AD) 风险增加30.7%有关.
- 患有OP的个体表现出较差的认知功能和减少的灰质体积.
- 口腔疼痛的缓解与较低的AD发生率和改善的认知/大脑指标相关.
结论:
- 口腔疼痛 (OP) 是阿尔茨海默病 (AD) 和认知障碍的重要危险因素.
- 保持口腔健康可能是减少AD风险的关键策略.
- 神经免疫通路,可能涉及Tau,可能调解OP和AD之间的关联.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


